amp;(&("#($ =1 2…;  '!#! ( ( ( !## -))%( -2351 :, 3-…;  ​&'(#&'($# 6ix — News, calls and decks from 54,000 public companies#039;( 6ix — News, calls and decks from 54,000 public companiesquot;"$##6ix — News, calls and decks from 54,000 public companies#039;#&6ix — News, calls and decks from 54,000 public companiesamp;!+…" /> amp;(&("#($ =1 2…;  '!#! ( ( ( !## -))%( -2351 :, 3-…;  ​&'(#&'($# 6ix — News, calls and decks from 54,000 public companies#039;( 6ix — News, calls and decks from 54,000 public companiesquot;"$##6ix — News, calls and decks from 54,000 public companies#039;#&6ix — News, calls and decks from 54,000 public companiesamp;!+…" /> amp;(&("#($ =1 2…;  '!#! ( ( ( !## -))%( -2351 :, 3-…;  ​&'(#&'($# 6ix — News, calls and decks from 54,000 public companies#039;( 6ix — News, calls and decks from 54,000 public companiesquot;"$##6ix — News, calls and decks from 54,000 public companies#039;#&6ix — News, calls and decks from 54,000 public companiesamp;!+…" />

Olema Pharmaceuticals, Inc. · NASDAQ:OLMA

Olema Pharmaceuticals — Investor Presentation (May 2023)

37 slides from Olema Pharmaceuticals's investor presentation, May 11, 2023

  1. Slide 1:  -        ​   -​

     -        ​   -​

  2. Slide 2: Forward-looking statements

     $&+&2 $$ #(("#(' ( %'(#))$# $#)#( $','8!$$ # ())"#)( " %*'(*#) )$ ) ( '$' %'$+($#( $ ) '+) *')( ))$# $'" -) $ BJJF3 ))"#)( # )( %'(#))$# )) ' #$) ())"#)( $ ()$'! ) ' $','8!$$ # ())"#)(3 * $',

  3. Slide 3:  #(,(#&($#$&!-1'$&(&("#($ =1 2 ('((​&'(#&3 ​4 05694+…

     #(,(#&($#$&!-1'$&(&("#($ =1 2 ('((​&'(#&3 ​4 05694+!% % ​$%0  0$$- /!# =/60 ​  "&!#"!% !"  " ! "%&!%%" 4(.) ​  " &)!$ ' %&)%

  4. Slide 4:  '!#! ( ( ( !## -))%( -2351 :, 3- $#$$​"#$" :1; ! "!"'%#,

     '!#! ( ( ( !## -))%( -2351 :, 3- $#$$​"#$" :1; ! "!"'%#, 3*'!*'"('​  '&'&&4 &;!''"!: :8:; ​" "%#,*'​ <1>#" &:+#!&"!"!"! ​" "%#,*'​ <1>%" &9"&&'"

  5. Slide 5:  ​&'(#&'($# $'( $""$##$'#&$&!+ #"!$ "**&" "$ !##…

     ​&'(#&'($# $'( $""$##$'#&$&!+ #"!$ "**&" "$ !## " "!"" !" '$(3%'" ")'$/)%$2-#'$$'%).4)($*'(@>@@2)( 7577*""#!(%) !%% "**% 

  6. Slide 6: 263!%&$","-&$","-* %&!.273 -#"-$".283"#!%.293%$" '%- (…

    263!%&$","-&$","-* %&!.273 -#"-$".283"#!%.293%$" '%- ($" '%-& %$" '%       -   - ​    ​                   - 

  7. Slide 7: ! "#('$&%-#=1 92 ​&'(#& ><>A$$&(% *%$)*#*)4"#$*($"*1 $%(#…

    ! "#('$&%-#=1 92 ​&'(#& ><>A$$&(% *%$)*#*)4"#$*($"*1 $%(#F5 >6 ​(,"$​) (!*%()*4:>D"()!'#'!'&&&( '") 2>?G:8D0%, %&'!%!!!(&%&()!'& !'4><>A

  8. Slide 8: " ##(!-+&$"%(#&$&"'$&91: #8  ​&("#( 76-') %#%!& 8687 :-')%#%!…

    " ##(!-+&$"%(#&$&"'$&91: #8  ​&("#( 76-') %#%!& 8687 :-')%#%!&8688 ( $)  0$ (% ​ '   0$ (% ​ <-')%#%!&8687 :-') %#%!&8688 4 ;$'$5( '*"()'$) ,(&&'%+.)44-%$ $*'.@E1@>@A4

  9. Slide 9: # 289;7/​'(2#2!''$(#(!$&=1 92 ​&'(#&    %#%! -%%#%' #! ! %*(/…

    # 289;7/​'(2#2!''$(#(!$&=1 92 ​&'(#&    %#%! -%%#%' #! ! %*(/  8/: ​   -   -     #     !"          ​$​

  10. Slide 10:    ! ​  ​     - !!"

       ! ​  ​     - !!"

  11. Slide 11:  /67:5 $6!$$%! $7!$(" $! . ! / '819$"#($#()-+(!$!/()-…

     /67:5 $6!$$%! $7!$(" $! . ! / '819$"#($#()-+(!$!/()-'# + " (&#"%'%.  E3 =4 ,%()*%(  ,#+#))5$)+(#%%&%4$)+(#6  G<'(&(&($&%#($%&(#&##/,%&($*)**

  12. Slide 12:  289;7'819#$"#($#+(!$! -2 !! '-+/)1!!!'//5$! …

     289;7'819#$"#($#+(!$! -2 !! '-+/)1!!!'//5$!  ,"!! $$"$"#$#  $ 3 F:A4      32  16(43 ​-   $ - .6)33* .. .-)01*       $ /0)46*  

  13. Slide 13:  289;7'819#$"#($#+(!$! !$!  (  *! - …

     289;7'819#$"#($#+(!$! !$!  (  *! - -&"D75A# '"'& /67:5#&  #B( )&'%"' 85!0"C81 ;5!0"C81 >5!0"C81 675!0"C751 - 0"C7>1  #!/80"C89:1 -  %& % D8 -  %& % D

  14. Slide 14:  289;7'819()-#$"#($#+(!$!  % "# -  #…

     289;7'819()-#$"#($#+(!$!  % "# -  # -​ $   #!-    ​-   ​ -   "  %​  "$'0$'!&$&"!2 3&)! #" !089

  15. Slide 15:  289;7'819()-#$"#($#+(!$!  *,-0+% "# ! !…

     289;7'819()-#$"#($#+(!$!  *,-0+% "# ! !&  $   #!-  ​   ​   -   "  -​​  "$'0$'!&$&"!2 3&)! #" !089

  16. Slide 16:  289;7'819#$"#($#+(!$! && !!​!*!& , "!…

     289;7'819#$"#($#+(!$! && !!​!*!& , "!! !!  -&(&+ "!%&$&!"& )&+#!8  #&!&%  $&$%#"!%%)$"%$(! (#&!&%&"&2"!"!$ . "'$'!"!$ 3  !!

  17. Slide 17: ! '8$"#($#()-+($! #-!%!'   7 CC ​ 2 :0<") #%$%)#(& + '%'3 …

    ! '8$"#($#()-+($! #-!%!'   7 CC ​ 2 :0<") #%$%)#(& + '%'3 '"'&*'  9 !(''#" 8178;6C # <66! 8178;6C - $ &966! #  <66! - $ & 966! !$$%! !$(" $! !% #$ 

  18. Slide 18: "  %"&  ​    -&$&&

    "  %"&  ​    -&$&&

  19. Slide 19: # 289;72778&'(2#2 )"#'819 $#$(&%-()-/()-'# ')&2-%*4*+$&(*,*/% $)+(#…

    # 289;72778&'(2#2 )"#'819 $#$(&%-()-/()-'# ')&2-%*4*+$&(*,*/% $)+(#))&&(*1)*/% *&#(#*/*= %!%,#')&2($&"%*)1)*/%*&#(#*/1%*/= #"%,#')&25E61​5EE

  20. Slide 20:  289;7'819$',%#'$# !!  #%! #   =@C"#&!&%$( 9"$ "$#…

     289;7'819$',%#'$# !!  #%! #   =@C"#&!&%$( 9"$ "$#$"$!%" &$#+!&(! %&&!.?9C(%$ %%  @=C$(#$"$  ;/=.?8C$( #$"$- ..=<C$( #$"$'(%&$!&  <@C&(&! '&

  21. Slide 21:  $'2&$%$&($#! +(%("!(-2((!'"$##(&($#' )"!"$G*(*%+).&%)+(…

     $'2&$%$&($#! +(%("!(-2((!'"$##(&($#' )"!"$G*(*%+).&%)+() %$ )*(%"6)+&&"#$*&("$"#%") 7G>>B$5# 87D)*+)82%**("$G+",)*($*  G>D#%)*A<<#,(/>D/) 1%$"/4 !-'%#&

  22. Slide 22:  <7"#897"$''!!$!&(#'819 $#$(&%- $',%#'$# -&"D6:A #'"'&"&…

     <7"#897"$''!!$!&(#'819 $#$(&%- $',%#'$# -&"D6:A #'"'&"&6.6 ;5! 0"C881 675! 0"C8:1 #' 0;5!2675!-"C;=1 %6 %7 D%8 %6 %7 D%8 %6.7 D%8 -%/- D B < <C > A 8<0:9A1 <065A1 +) C = ;

  23. Slide 23:  ##)!-#(2)"$&-(*(-#289;7$',%#'$# *$* $+$%$(#&(*"()&%$)$"*(&(%…

     ##)!-#(2)"$&-(*(-#289;7$',%#'$# *$* $+$%$(#&(*"()&%$)$"*(&(%())*)+)'+$*)$4 (! )%.)$*#+**%$&()$*1"*)%.)$*-"6*/&1$*)$%%.$*)#))$*4 - 1(%#*)$

  24. Slide 24:  !&-#)&!!#!​#(# *!-&(&($%)!($# %" %.)$*#+**%$&(…

     !&-#)&!!#!​#(# *!-&(&($%)!($# %" %.)$*#+**%$&()$*1%&$%.)$*-"6*/&1$*)$%%.$*)#))$*4 9$%$(#&(*"()&%$))-*$%$(#*%$*)+)'+$*)$4 - 1(%#*)$*%

  25. Slide 25:  '819$',%#'$#)""&- *,-0+   .*& !$! !**  5!"!% …

     '819$',%#'$#)""&- *,-0+   .*& !$! !**  5!"!% #%'%&#"!&&*'!"!% '"!'&(&$(!'&!0 55"(%/ - &;'%!​ <1>!'"%2+#%!:1; #'!'&. "(%!"​!!"",0 '('&

  26. Slide 26:  *!$&(&("#( "%(',%(-#9 ==1 92 ​       …

     *!$&(&("#( "%(',%(-#9 ==1 92 ​         -​   "'$/​$ %'## !&"' !&%7577 . !&"(756:0 7</< !# 7/? !# "!28 3  $29 D3 *'0 &'$%# %  #.7 A! !%#")/ 

  27. Slide 27: ! -       '  

    ! -       '  

  28. Slide 28: " %!--*##289;7$+&*$(!':()' ,  "!"&$#+ %8"%%&"! %8…

    " %!--*##289;7$+&*$(!':()' ,  "!"&$#+ %8"%%&"! %8"%*#!%"! #&+$"&#"';5!"675! #!$ '"%# !"'"C:; %9 )+(# )) &%4$)+(# )) *) 4 +5  $" !5 #!$ '"%# !"'"C:

  29. Slide 29: # !*&#$#!)&(# !'($#'#979: %#! $"!$%! !26<;,5 ! %!$&""!#% '!" %…

    # !*&#$#!)&(# !'($#'#979: %#! $"!$%! !26<;,5 ! %!$&""!#% '!" % !"#%! $ %!757: 9?:-(%' A?1@>@A4 %%5#$ '!%$7 05694 ! !%#"* %#667 #$ %$6 05694 ! !%#"* % 667 #$ %$6 0

  30. Slide 30:  #(,(#&($#$&!-1'$&(&("#($ =1 2 ('((​&'(#&3 ​4 05694…

     #(,(#&($#$&!-1'$&(&("#($ =1 2 ('((​&'(#&3 ​4 05694+!% % ​$%0  0$$- /!# =/60 ​  "&!#"!% !"  " ! "%&!%%" 4(.) ​  " &)!$ ' %&)%

  31. Slide 31:  ")&'#% '#"& ")&'#%  '# '>$!"3$"  ">$!"3$" ​(&"&&) #$!"' ​(&"&& ) #$!"'

     ")&'#% '#"& ")&'#%  '# '>$!"3$"  ">$!"3$" ​(&"&&) #$!"' ​(&"&& ) #$!"' %')#'#>$!"3$" %%& %%& ''(>$!"3$"

  32. Slide 32:  -  #%&($!   - 

     -  #%&($!   - 

  33. Slide 33:  05694"!% %* !"%* %'%$%$%#! "%!#12+!$0#' %# $#"%! %'%*+…

     05694"!% %* !"%* %'%$%$%#! "%!#12+!$0#' %# $#"%! %'%*+  %$0#' #$% ##!(%+ $%#! * &$#%! ! 289;7/$"%!('(&$#%($&-($#'( 3-4 '$(3$$​'%,$11@

  34. Slide 34:  Vehicle 1nM E2 Fulvestrant OP-1250 Camizestrant Amcenestrant Giredestrant Rintodestrant Elacestrant ARV-471 Lasofo…

     Vehicle 1nM E2 Fulvestrant OP-1250 Camizestrant Amcenestrant Giredestrant Rintodestrant Elacestrant ARV-471 Lasofoxifene Tamoxifen 0 20 40 60 80 100 120 140 160 180 200 CERANs partial AF1 agonists strong AF1 agonists MCF-7 Vehicle 1nM E2 Fulvestrant OP-1250 Camizestrant Amcenestrant Giredestrant

  35. Slide 35:  -1' #(*(​$(-85-9-(*(-. ! 1'#!- #(*(-9 -10 -9 -8 -7 -6 0 20 40

     -1' #(*(​$(-85-9-(*(-. ! 1'#!- #(*(-9 -10 -9 -8 -7 -6 0 20 40 60 80 100 120 Log [M] Alkaline Phophatase Activity (%E2) full agonists on AF-1 partial agonists on AF-1 complete antagonists on AF-1 no E2 Emax (%E2) 90.0 88.1 84.1 49.1 20.9 9.0 7.4 7.1

  36. Slide 36:  #$&(-()'/289;7*'0)!*'(&#( %'(+& !! "-  "!! …

     #$&(-()'/289;7*'0)!*'(&#( %'(+& !! "-  "!!  0;16/ &2 5944 <85  0457

  37. Slide 37: ! 289;7 '"$#'(&(-(*(-# ('('' $!' --7576+ %## ​#$% #​#  %$%$$…

    ! 289;7 '"$#'(&(-(*(-# ('('' $!' --7576+ %## ​#$% #​#  %$%$$ !#%%&) 65!./67:5&&($%#%'#'!#+"-( )&'%"' "#)%'#!,"&%""!('"'6/:8<'(!#%&"""'%%" !# #B%&' "%%"!'&'

Olema Pharmaceuticals — Investor Presentation (May 2023) on 6ix